Brief: Chemometec FY EBITDA Up At DKK 222.9 Million

ChemoMetec A/S

15/09/2022 14:43

Sept 15 (Reuters) - Chemometec A/S  CHEMM.CO :
    * ANNUAL REPORT 2021/22 - STRONG GROWTH DESPITE CHALLENGING
CONDITIONS
    * GREW ITS REVENUE BY 52% IN 2021/22 FROM DKK 281.1 MILLION
TO DKK
427.2 MILLION
    * REVENUE GROWTH WAS DRIVEN BY INCREASED SALES OF
INSTRUMENTS,
CONSUMABLES, AND SERVICES IN ALL KEY GEOGRAPHIES
    * BOARD OF DIRECTORS PROPOSES TO GENERAL MEETING THAT NO
DIVIDEND
BE DISTRIBUTED FOR 2021/22 FINANCIAL YEAR
    * ANNUAL REVENUE AND EBITDA ARE IN LINE WITH MOST RECENT
GUIDANCE
ANNOUNCED ON 15 AUGUST 2022 BUT ARE SIGNIFICANTLY HIGHER THAN
GUIDANCE PRESENTED IN 2020/21 ANNUAL REPORT
    * FOR 2022/23, CHEMOMETEC EXPECTS REVENUE IN RANGE OF DKK
485-505
MILLION AND EBITDA IN RANGE OF DKK 245-260 MILLION
    * INVESTMENT IN E.G. PRODUCT DEVELOPMENT, PRODUCTION
FACILITIES,
AND INTANGIBLE ASSETS IS EXPECTED TO AMOUNT TO APPROXIMATELY DKK
70 MILLION
    * FY EBITDA WAS DKK 222.9 MILLION, AN INCREASE OF DKK 87.3
MILLION
RELATIVE TO 2020/21, AND EBITDA MARGIN WAS 52%, AGAINST 48%
PREVIOUS YEAR

Source text for Eikon:  ID:nGNEcckbvS 
Further company coverage:  CHEMM.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))